{Reference Type}: Journal Article
{Title}: Therapeutic Myths in Solid Organ Transplantation Infectious Diseases.
{Author}: Goodlet KJ;McCreary EK;Nailor MD;Barnes D;Brokhof MM;Bova S;Clemens E;Kelly B;Lichvar A;Pluckrose DM;Summers BB;Szempruch KR;Tchen S;
{Journal}: Open Forum Infect Dis
{Volume}: 11
{Issue}: 7
{Year}: 2024 Jul
{Factor}: 4.423
{DOI}: 10.1093/ofid/ofae342
{Abstract}: Infection management in solid organ transplantation poses unique challenges, with a diverse array of potential pathogens and associated antimicrobial therapies. With limited high-quality randomized clinical trials to direct optimal care, therapeutic "myths" may propagate and contribute to suboptimal or excessive antimicrobial use. We discuss 6 therapeutic myths with particular relevance to solid organ transplantation and provide recommendations for infectious diseases clinicians involved in the care of this high-risk population.